Advanced search
Publication Cover
European Clinical Respiratory Journal Volume 3, 2016 - Issue 1
Submit an article Journal homepage
875
Views
13
CrossRef citations to date
0
Altmetric
Original Research Articles

NT-proBNP <95 ng/l can exclude pulmonary hypertension on echocardiography at diagnostic workup in patients with interstitial lung disease

Charlotte AndersenDepartment of Clinical Pharmacology, Aarhus University Hospital, Aarhus, DenmarkCorrespondence[email protected]
,
Søren MellemkjærDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark
,
Ole HilbergDepartment of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark
&
Elisabeth BendstrupDepartment of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark
Article: 32027 | Received 22 Apr 2016, Accepted 07 Jul 2016, Published online: 28 Jul 2016

References

  • Andersen CU, Mellemkjaer S, Hilberg O, Nielsen-Kudsk JE, Simonsen U, Bendstrup E. Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test. Respir Med. 2012; 106: 875–82.
  • Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, etal. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med. 2003; 167: 735–40.
  • Andersen CU, Mellemkjaer S, Nielsen-Kudsk JE, Bendstrup E, Hilberg O, Simonsen U. Pulmonary hypertension in chronic obstructive and interstitial lung diseases. Int J Cardiol. 2013; 168: 1795–804.
  • Foris V, Kovacs G, Tscherner M, Olschewski A, Olschewski H. Biomarkers in pulmonary hypertension: what do we know?. Chest. 2013; 144: 274–83.
  • Andersen CU, Mellemkjaer S, Nielsen-Kudsk JE, Bendstrup E, Simonsen U, Hilberg O. Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease. Respir Med. 2012; 106: 1749–55.
  • Rosenberg E. The 1995 update of recommendations for a standard technique for measuring the single-breath carbon monoxide diffusing capacity (transfer factor). Am J Respir Crit Care Med. 1996; 154: 827–8.
  • Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J Suppl. 1993; 16: 41–52.
  • ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166: 111–17.
  • Mair J. Biochemistry of B-type natriuretic peptide – where are we now?. Clin Chem Lab Med. 2008; 46: 1507–14.
  • Tiede SL, Gall H, Dorr O, Troidl C, Liebetrau C, Voss S, etal. New potential diagnostic biomarkers for pulmonary hypertension. Eur Respir J. 2015; 46: 1390–6.
  • Wieshammer S, Dreyhaupt J, Basler B, Marsovszky E. NT-proBNP for pulmonologists: not only a rule-out test for systolic heart failure but also a global marker of heart disease. Respiration. 2009; 77: 370–80.
  • Bonderman D, Wexberg P, Martischnig AM, Heinzl H, Lang MB, Sadushi R, etal. A noninvasive algorithm to exclude pre-capillary pulmonary hypertension. Eur Respir J. 2011; 37: 1096–103.
  • Raghu G, Nathan SD, Behr J, Brown KK, Egan JJ, Kawut SM, etal. Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction. Eur Respir J. 2015; 46: 1370–7.
  • Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, etal. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006; 174: 1034–41.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.